07|02|25

The Omnichannel Advantage: Insights from Dan Gandor at the DHC Roundtable

Discover how EVERSANA INTOUCH’s Dan Gandor is redefining omnichannel strategy in pharma. Key takeaways from the DHC Roundtable at Amgen reveal scalable innovations from rare disease marketing.

07|01|25

Cannes 2025: Lessons in Branding, AI and the Rise of Creator Content

In his PharmaLive article, John Kenny explores how brands have shifted from speculating about AI to integrating it into creative workflows. From collapsing production timelines to evolving influencer content, discover how AI is reshaping pharma marketing.

06|24|25

Cannes 2025: Pharma’s Creative Inflection Point

In her latest PharmaLive article, Susan Perlbachs, Chief Creative Officer at EVERSANA INTOUCH, reflects on three key themes from this year’s Cannes Lions Festival of Creativity—each signaling a new era for pharmaceutical marketing.

06|16|25

MM+M Top 100 2025: Evolved for Where Pharma’s Going

Discover how EVERSANA INTOUCH secured a top 10 spot in the MM+M Agency 100 list and learn how we've evolved for where pharma's going with a unique approach to pharma marketing.

06|13|25

AI in Oncology: Solving the Sequencing Puzzle in a Biomarker-Driven Era

At ASCO 2025, artificial intelligence took center stage as a real-world solution to one of oncology’s most complex challenges: sequencing treatments in a rapidly expanding biomarker landscape. In a recent PharmaLive article, Tim Lewis, EVP of Strategic Development, Oncology and Precision Medicine at EVERSANA INTOUCH, shared how AI is helping oncologists make faster, smarter decisions when evidence is […]

06|12|25

Inside Google’s AI Mode: Exploring Differentiators to Other AI-Search Options

Google’s AI Mode is fundamentally changing how people find health information online. For pharma marketers, this presents a critical opportunity to build trust and ensure compliance by optimizing content for AI, adapting how we advertise and measuring success. Ensure your brand is prepared. Download the POV to learn more.

06|10|25

AI, Biomarkers & The Future of Oncology: Expert Insights From ASCO 2025 

At this year’s ASCO Annual Meeting, the future of oncology came into sharper focus — and EVERSANA INTOUCH was at the center of the conversation. From the expanding role of AI to the evolving biomarker landscape, our experts shared insights that are shaping the future of cancer care. 

06|02|25

2025 Pharma Generative Search Report

Generative AI has rapidly reshaped the pharma landscape, embedding itself into nearly every digital tool we use. With platforms like Google’s AI Overviews and ChatGPT redefining search, pharma marketers must rethink how they reach and engage audiences in this evolving ecosystem. Our innovative SEO team conducted a comprehensive analysis within the pharma industry. Download the report to see our findings.

05|21|25

Big Moves for Bigger Impact: Elevating Agency Leadership to Enhance Client Success

EVERSANA INTOUCH announced new leadership appointments in a recent press release. Read the blog for details about the leadership changes and how they will enhance client success.

05|09|25

PM360 ELITE 100: A Visionary Creative Leader Redefining Healthcare Advertising

Each year, PM360 shines a spotlight on the visionaries, innovators and trailblazers who are transforming the healthcare and life sciences industries. We’re proud to celebrate Katie Beller, SVP, Group Creative Director, as a 2025 PM360 ELITE 100 winner in the creative directors category. Read the blog to learn more.